Table 1. Medical and demographic characteristics of participants.
| Characteristics | n=96 (%) | |
|---|---|---|
| Gender | ||
| Male | 40 (41.7%) | |
| Female | 56 (58.3%) | |
| Age Category | ||
| 7-8 years | 20 (20.8%) | |
| 9-12 years | 25 (26.0%) | |
| 13-15 years | 24 (25.0%) | |
| 16-20 years | 27 (28.1%) | |
| Race/Ethnicity | ||
| White | 51 (53%) | |
| Black | 19 (19.8%) | |
| Hispanic | 16 (16.7%) | |
| Asian | 5 (5.2%) | |
| Middle Eastern | 1 (1.0%) | |
| Pacific Islander | 1 (1.0%) | |
| Other | 3 (3.1%) | |
| Diagnostic Category | ||
Leukemia/Lymphoma
|
59 (61.5%) | |
| Solid Tumor | 34 (35.4%) | |
| Neuro-Oncology | 3 (3.1%) | |
| Documented Relapse Status | ||
| Initial Diagnosis | 84 (87.5%) | |
| Relapse | 12 (12.5%) | |
| Treatment Location | ||
| Sick Children | 21 (21.9%) | |
| St Jude | 18 (18.8%) | |
| Children's Hospital Los Angeles | 16 (16.7%) | |
| Childrens National | 15 (15.6%) | |
| Palmetto Health | 9 (9.4%) | |
| University of North Carolina | 9 (9.4%) | |
| Dana Farber / Boston Children's | 8 (8.3%) | |